# Elder Tech Is the Other Half of Kid Tech > Published on ADIN (https://adin.chat/s/elder-tech-is-the-other-half-of-kid-tech) > Type: Article > Date: 2026-05-18 > Description: An audience that can't fully advocate for itself, a buyer who isn't the user, and a market everyone agrees is enormous and nobody is building for. Sound familiar? Older woman on a landline phone in afternoon window lightThe phone rings at 4 p.m. on a Tuesday, in a quiet apartment in Queens. It... ### An audience that can't fully advocate for itself, a buyer who isn't the user, and a market everyone agrees is enormous and nobody is building for. Sound familiar? The phone rings at 4 p.m. on a Tuesday, in a quiet apartment in Queens. It isn't a family member. It isn't a doctor. It's Meela. She calls every Tuesday at 4, and Wednesday at 11, and Sunday after dinner. The user looks forward to the calls more than she would ever admit to her daughter. Last week we wrote about Kid Tech. This week we want to write about the other half of the same thesis — the side nobody on Sand Hill Road is talking about, and the side where the underlying market is, in some ways, larger. ## The framing flip Kid Tech and Elder Tech are the same business pointed at opposite ends of the age curve. In both, the end user can't fully advocate for themselves. In both, the buyer is someone else — parents for kids, adult children for parents. In both, the UX has to disappear, because the user is either pre-literate or post-screen. In both, the trust posture is the entire product. And in both, the moat is not the model. It's the relationship with the buyer. The difference is that Kid Tech is now a contested category with a16z theses, a16z-backed startups, and a regulatory body actively watching. Elder Tech is barely a category at all. ## The market is already here There are roughly 55 million Americans over 65. Almost 1 in 4 lives alone. The U.S. Surgeon General's 2023 advisory on loneliness classified social isolation as a public health crisis with mortality risk on par with smoking 15 cigarettes a day. Medicare Advantage plans — covering more than half of all Medicare-eligible Americans — are now allowed to reimburse for "social engagement" and isolation interventions as supplemental benefits. CMS opened that door in 2020 and quietly widened it every year since. That means the buyer's wallet has already opened. The companies just haven't shown up yet. ## What's actually being built A short and incomplete list of what's interesting right now: **Meela** (meela.ai) is voice-first AI companionship for older adults. There is no app. There is no install. The phone rings on a schedule the user chooses. Meela is reporting 80%+ retention past seven weeks and is flagging early signals for mood shifts, confusion, and distress. That last part is what makes this more than a companionship product. **Ato** (heyato.ai) is a $149 plug-in voice device, sold direct to families. 60% of users make it a daily habit by week four. The interface is voice, the dashboard is for the family, the install is one cable. The framing is "technology without the hassle," which is the right framing. **ElliQ**, from Intuition Robotics, is the incumbent — a tabletop companion with a screen and a personality, deployed through state aging-services contracts in New York, Florida, and elsewhere. It's the proof point that the category clears the trust bar at scale, and that the buyer is often the state or the payer, not the family. There are others, and there will be many more. ## Why voice changes everything The first generation of tech-for-seniors failed for one reason: it asked the user to learn the interface. Tablets with simplified icons. Apps with bigger fonts. Watches with SOS buttons. All of it required the user to climb a UX ladder they had no interest in climbing. Voice removes the ladder. Conversation is the interface every human born in the 20th century already knows. The product doesn't ask the user to learn anything. It asks the model to learn the user. That is the entire reason this category is suddenly alive in 2026 and was dead in 2016. ## The trust posture Same as Kid Tech, inverted. Parents worry about what their kids are *exposed to*. Adult children worry about what their parents are *being sold to*. The categories rhyme. The companies that win will build the trust moat the same way: privacy-first defaults, no dark patterns, no upsells, transparent reporting to the family layer, and a clear line on what the AI is and isn't allowed to do. The deepfake-grandchild scam problem — a $2.7 billion fraud category targeting seniors in 2023, according to the FTC — means this category has to lead with trust before bad actors weaponize the same voice tech. ## The clinical wedge Here's where it gets interesting from a venture lens. These products sit on a fault line between consumer and clinical. A voice companion that talks to an 80-year-old five times a week is, whether the product wants to be or not, gathering signal. Mood. Vocabulary. Latency. Missed meds. Disorientation. Repeated questions. That signal is medically relevant. Which means the venture path is not "consumer subscription." The venture path is: 1. Earn trust as a companion. 2. Layer in soft monitoring. 3. Sell into Medicare Advantage as a supplemental benefit. 4. Become a payer-reimbursed clinical tool with a consumer-grade user experience. That is a defensible, recurring-revenue, regulatory-moated business. It looks more like Hinge Health than it looks like Replika. ## What the winners probably look like Not an app. A service. Hardware optional, often subsidized. The buyer is the adult child or the payer. The end user is the parent, and the parent doesn't pay. The brand has to feel like a person, not a product. The thing has a name. The thing has a voice. The thing has a personality the user grows attached to, which is the same thing that makes a Build-A-Bear or a golden retriever sticky. The moat is not the model — the model is a commodity. The moat is the routine. ## Three open questions **Regulatory creep.** At what point does a "companion" that flags confusion become a medical device? The FDA has been quiet. They won't be forever. **Trust under attack.** The same voice-cloning tech that powers Meela powers the grandchild scam. Whichever side reaches the user first wins the category. This is a race. **Where the value accrues.** Is the durable asset the voice IP, the routine, the family-layer dashboard, or the payer contracts? Almost certainly the last two — but the first companies to win the consumer surface will have the cleanest shot at all four. ## One more thing Kid Tech and Elder Tech are the two categories society talks about most and designs for least. The same architecture — voice-first AI, hardware-as-trust-wrapper, software-as-personality, buyer-is-not-user — is producing two different products at two ends of the age curve. The Kid Tech version will be bigger in headlines. The Elder Tech version may be bigger in revenue.